$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Controlled release powder and process for its preparation 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/58
  • A61K-009/60
  • A61K-009/68
  • A61K-009/26
출원번호 US-0169447 (1988-03-17)
우선권정보 IE-0002788 (1984-10-30)
발명자 / 주소
  • Sparks Randall T. (Gainesville GA) Geoghegan Edward J. (Athlone IEX)
출원인 / 주소
  • Elan Corporation, p.l.c. (Athlone IEX 03)
인용정보 피인용 횟수 : 237  인용 특허 : 24

초록

A controlled release powder containing discrete micro-particles for use in edible, pharmaceutical and other controlled release compositions is disclosed. The micro-particles have an average size in the range of from 0.1 to 125 m

대표청구항

A controlled release taste masked powder containing discrete micro-particles for use in edible pharmaceutical and other controlled release compositions, said powder comprising particles containing an active ingredient in intimate admixture with at least one non-toxic insoluble, permeable, impermeabl

이 특허에 인용된 특허 (24)

  1. Taskis Charles B. (Worthing GB2), Coated particles.
  2. Ludwig Nelson H. (Greenfield IN) Ose Earl E. (Greenfield IN), Controlled release formulations and method of treatment.
  3. Trill Anthony J. (Horsham GB2), Delayed release formulations and processes for making them.
  4. Hsiao Chiin H. (Cooper City FL), Dry sustained release theophylline oral formulation.
  5. Sair Louis (Evergreen Park IL) Sair Ralph A. (Lincolnwood IL), Encapsulation of active agents as microdispersions in homogeneous natural polymeric matrices.
  6. Hall Harlan S. (Black Earth WI) Pondell Ralph E. (Madison WI), Encapsulation of vitamin and mineral nutrients.
  7. Vaughn John (P.O. Box 3368 Granada Hills CA 91344), High torque fastener and driving tool.
  8. Naito Kenji (Odawara JPX) Ohe Keitaro (Odawara JPX) Tsuji Nobuo (Minami-ashigara JPX), Method of producing finely divided polymer particles.
  9. Monsimer Harold G. (Norristown PA) Bohm Howard A. (Harleysville PA), Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use.
  10. Tice Thomas R. (Helena AL) Lewis Danny H. (Gardendale AL), Microencapsulation process.
  11. Speaker Tully J. (Philadelphia PA) Lesko Lawrence J. (Houston TX), Microparticulate material and method of making such material.
  12. Benedikt ; Gerald, New oral form of medicament and a method for producing it.
  13. Pedersen Arne Martinus (Vanlose DK), Oral drug preparations.
  14. Seager Harry (Worthing EN), Pharmaceutical formulations.
  15. DeLuca Patrick P. (Lexington KY) Kanke Motoko (Fukuyama JPX) Sato Toyomi (Tokyo CA JPX) Schroeder Hans G. (Encinitas CA), Porous microspheres for drug delivery and methods for making same.
  16. Morishita Masataka (Shizuoka JA) Inaba Yoshihito (Shizuoka JA) Fukushima Mitsuru (Shizuoka JA) Kobari Sadami (Shizuoka JA) Nagata Akiho (Shizuoka JA) Abe Jinnosuke (Shizuoka JA), Preparation of microcapsules.
  17. Fong, Jones W., Process for preparation of microspheres.
  18. Couvreur Patrick (Wezembeek-Oppem BEX) Roland Michel (Brussels BEX) Speiser Peter (Forch CHX), Process for preparing biodegradable submicroscopic particles containing a biologically active substance and their use.
  19. Kobayashi ; Toshiyuki ; Okada ; Akio ; Mayama ; Takeshi ; Okada ; Akira, Process for preparing preparations for oral administration.
  20. Kitajima Masao (Asaka JA) Kondo Asaji (Asaka JA) Arai Fuminori (Asaka JA), Process of producing aspirin-containing capsules.
  21. Beatty Morgan L. (Pfizer Inc. ; 235 E. 42nd St. New York NY 10017), Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration.
  22. Alderman Daniel A. (Midland MI) Wolford Troy D. (Midland MI), Sustained release dosage form based on highly plasticized cellulose ether gels.
  23. Yu Andrew B. C. (Albany NY) John Phillip M. (East Greenbush NY), Sustained-release pharmaceutical tablet and process for preparation thereof.
  24. Keller Hans E. (Riehen CHX) Klaeui Heinrich (Riehen CHX), Vitamin A compositions.

이 특허를 인용한 특허 (237)

  1. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Abuse deterrent compositions and methods of making same.
  2. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Abuse deterrent compositions and methods of making same.
  3. Dharmadhikari, Nitin Bhalachandra; Zala, Yashoraj Rupsinh; Shanghvi, Dilip, Abuse deterrent immediate release coated reservoir solid dosage form.
  4. Dharmadhikari, Nitin Bhalachandra; Zala, Yashoraj Rupsinh; Shanghvi, Dilip, Abuse deterrent immediate release coated reservoir solid dosage form.
  5. Shah Shirish A. ; Ho Chris Y., Acetaminophen sustained-release formulation.
  6. Kositprapa, Unchalee; Sriwongjanya, Mongkol, Antihistamine and decongestant system.
  7. Nicolson, Donald Magnus; Halliday, Janet Anne; Tuominen, Jukka; Zurutuza, Amaia, Bioresorbable polymers.
  8. Davis Paula Denise (Cincinnati OH) Dobrozsi Douglas Joseph (Cincinnati OH) Kelm Gary Robert (Cincinnati OH) Mandel Kenneth Gary (Fairfield OH), Bisacodyl dosage form.
  9. Kelm Gary Robert (Cincinnati OH) Manring Gary Lee (Hamilton OH) Davis Paula Denise (Cincinnati OH) Dobrozsi Douglas Joseph (Loveland OH) Mandel Kenneth Gary (Fairfield OH) McCauley-Meyers David Lee (, Bisacodyl dosage form for colonic delivery.
  10. Hair, Gregory A.; Boden, Scott D., Bone mineralization proteins, DNA, vectors expression systems.
  11. Gregory A. Hair ; Scott D. Boden, Bone mineralization proteins, DNA, vectors, expression systems.
  12. Hair Gregory A. ; Boden Scott D., Bone mineralization proteins, DNA, vectors, expression systems.
  13. Hair, Gregory A.; Boden, Scott D., Bone mineralization proteins, DNA, vectors, expression systems.
  14. Summerville, James Peter, Broad-spectrum anti-emetic compositions and associated methods.
  15. Gao, Danchen; Hlinak, Anthony J.; Mazhary, Ahmad M.; Truelove, James E.; Vaughn, Margaret B., Celecoxib compositions.
  16. Upson James G. (Springdale OH) Russell Carmelita M. (Cincinnati OH), Chewable calcium carbonate antacid tablet compositions.
  17. Ratnaraj Sheila (Telford PA) Reilly ; Jr. William J. (New Hope PA), Chewable pharmaceutical tablets.
  18. Boghani, Navroz; Gebreselassie, Petros; Vyakaranam, Kiran, Chewing gum composition comprising encapsulated acid.
  19. Albert,Kenneth Stephen; Maes,Paul Jos챕, Chronotherapeutic diltiazem formulations and the administration thereof.
  20. Oronsky, Bryan T.; Oronsky, Neil C., Combination therapy for bipolar disorder.
  21. Serdyuk, Sergey, Composition and method for potentiating drugs.
  22. Baird, Andrew; Gonzalez, Ana Maria; Logan, Ann; Berry, Martin, Compositions and methods for delivery of agents for neuronal regeneration and survival.
  23. Kumar, Vijai; Dixon, David; Tewari, Divya; Wadgaonkar, Dilip B., Compositions for deterring abuse of opioid containing dosage forms.
  24. Berlin, Roger G., Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines.
  25. Hanna, Mazen H.; York, Peter, Compositions of particulate coformulation.
  26. Leung, Karling Alice, Compositions, devices and methods of use thereof for the treatment of cancers.
  27. Brem Henny ; Langer Robert S. ; Domb Abraham J.,ILX, Controlled local delivery of chemotherapeutic agents for treating solid tumors.
  28. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  29. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  30. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  31. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  32. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  33. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  34. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  35. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  36. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  37. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  38. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  39. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  40. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  41. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Controlled release hydrocodone formulations.
  42. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  43. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  44. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  45. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  46. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  47. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  48. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  49. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  50. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  51. Chen,Chih Ming; Cheng,Xiu Xiu, Controlled release oral dosage form of beta-adrenergic blocking agents.
  52. Venkatesh, Gopi; Kramer, Craig, Controlled release potassium chloride tablets.
  53. Didier Gagnebien FR; Beatrice DeFossez FR; Sophie Lecomte FR, Cosmetic composition in the form of a molded powder cake containing hollow microcapsules and their preparation.
  54. Cartilier Louis (Beaconsfield CAX) Mateescu Mircea A. (Verdun CAX) Dumoulin Yves (Ste-Julie CAX) Lenaerts Vincent (Paris FRX), Cross-linked amylose as a binder/disintegrant in tablets.
  55. Boghani, Navroz; Gebreselassie, Petros; Kiefer, Jesse J., Delivery system for active components and a material having preselected hydrophobicity as part of an edible composition.
  56. Boghani, Navroz; Gebreselassie, Petros, Delivery system for active components as part of an edible composition having preselected tensile strength.
  57. Boghani, Navroz; Gebreselassie, Petros, Delivery system for active components as part of an edible composition having selected particle size.
  58. Boghani, Navroz; Gebreselassie, Petros, Delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component.
  59. Boghani, Navroz; Gebreselassie, Petros, Delivery system for coated active components as part of an edible composition.
  60. Boghani, Navroz; Gebreselassie, Petros, Delivery system for two or more active components as part of an edible composition.
  61. Platz,Robert M.; Patton,John S.; Foster,Linda; Eljamal,Mohammed, Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments.
  62. Alessi, Thomas R.; Leung, Karling Alice; Mercer, Ryan D.; Negulescu, Cristina G.; Rohloff, Catherine M.; Yang, Bing, Devices, formulations, and methods for delivery of multiple beneficial agents.
  63. Chen, Chih-Ming; Cheng, Xiu Xiu; Jan, Steve, Diltiazem controlled release formulation and method of manufacture.
  64. Platz, Robert M.; Brewer, Thomas K.; Boardman, Terence D., Dispersible macromolecule compositions and methods for their preparation and use.
  65. deVries, Tina; Gold, Lynn, Doxycycline metal complex in a solid dosage form.
  66. Boghani, Navroz; Gebreselassie, Petros, Edible composition including a delivery system for active components.
  67. Moe, Derek, Effervescent oral opiate dosage forms and methods of administering opiates.
  68. Boghani, Navroz; Gebreselassie, Petros; Vyakaranam, Kiran, Encapsulated acid, method for the preparation thereof, and chewing gum comprising same.
  69. Finch Charles W., Encapsulated plant growth regulator formulations.
  70. Rademacher Wilhelm,DEX ; Helpert Charles W. ; Finch Charles W. ; Callan Mary,DEX ; von Amsberg Hans, Encapsulated plant growth regulator formulations and applications.
  71. Yan, Nianxi, Encapsulation.
  72. Boyle Stasia ; Chang Kuei-Tu, Encapsulation of oleophilic substances and compositions produced thereby.
  73. Boyle Stasia ; Chang Kuei-Tu, Encapsulation of oleophilic substances and compositions produced thereby.
  74. Boyle Stasia ; Chang Kuei-Tu, Encapsulation of oleophilic substances and compositions produced thereby.
  75. Boyle Stasia ; Chang Kuei-Tu, Encapsulation of oleophilic substances and compositions produced thereby.
  76. Boyle Stasia ; Chang Kuei-Tu, Encapsulation of oleophilic substances and compositions produced thereby.
  77. Tarara, Thomas E.; Weers, Jeffry G.; Kabalnov, Alexey; Schutt, Ernest G.; Dellamary, Luis A., Engineered particles and methods of use.
  78. Tarara,Thomas E.; Weers,Jeffry G.; Kabalnov,Alexey; Schutt,Ernest G.; Dellamary,Luis A., Engineered particles and methods of use.
  79. Anaebonam Aloysius O. ; Clemente Emmett ; Mendes Robert W., Extended release acetaminophen.
  80. Clemente Emmett ; Anaebonam Aloysius O. ; Mendes Robert W. ; Fawzy Abdel A. ; Morrel Eric M., Extended release acetaminophen particles.
  81. Kirschner Mitchell I. ; Paradissis George ; Levinson R. Saul, Folic acid supplement.
  82. Sriwongjanya,Mongkol; Yuk,Samuel; Nangia,Avinash, Formulation and process for drug loaded cores.
  83. Tarara, Thomas E.; Weers, Jeffry G.; Eldon, Michael A.; Narashimhan, Rangachari; Clark, Andrew, Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use.
  84. Bakan, Douglas A.; Jitpraphai, Waranush; Newhard, Steven B.; Wortzman, Mitchell S., Gastroretentive dosage forms for doxycycline.
  85. Bonadio Jeffrey ; Goldstein Steven A., Gene transfer into bone cells and tissues.
  86. Tuominen, Jukka; Zurutuza, Amaia; Livingstone, Mark Alexander; Halliday, Janet Anne, Hydrophilic polyurethane compositions.
  87. Tuominen, Jukka; Zurutuza, Amaia; Livingstone, Mark; Halliday, Janet Anne, Hydrophilic polyurethane compositions.
  88. Shah Shirish A. ; Ho Chris Y., Immediate release/sustained release compressed tablets.
  89. Smith, Jay S.; Cole, Michael R.; Whitson, Amy K., Implant placement guide.
  90. Smith, Jay S.; Cole, Michael R.; Whitson, Amy K., Implant placement guide.
  91. Goldstein Steven A. ; Bonadio Jeffrey, In vivo gene transfer methods for wound healing.
  92. Chou, Kang-Jye; Guo, Hong; Ashton, Paul; Shimizu, Robert W.; Watson, David A., Injectable sustained release delivery devices.
  93. Cefali, Eugenio A.; Bova, David J., Intermediate release nicotinic acid compositions for treating hyperlipidemia.
  94. Cefali, Eugenio A., Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics.
  95. Sterling William R. (138 Konner Ave. Pine Brook NJ 07058), Low dose temazepam.
  96. Sterling William R. (Pine Brook NJ), Low dose temazepam.
  97. Chudzik, Stephen J.; Everson, Terrence P.; Amos, Richard A., Medicament incorporation matrix.
  98. Mathiowitz Edith (Brookline MA) Bernstein Howard (Cambridge MA) Morrel Eric (Needham MA) Schwaller Kirsten (Duxbury MA), Method for producing protein microspheres.
  99. Ashton, Paul, Method for treating and/or preventing retinal diseases with sustained release corticosteroids.
  100. Muhammad, Naweed; Jamieson, Gene Curtis; Bley, Keith R.; Chanda, Sanjay, Methods and compositions for administration of TRPV1 agonists.
  101. Muhammad, Naweed; Jamieson, Gene Curtis; Bley, Keith R.; Chanda, Sanjay, Methods and compositions for administration of TRPV1 agonists.
  102. Muhammad, Naweed; Jamieson, Gene Curtis; Bley, Keith R.; Chanda, Sanjay, Methods and compositions for administration of TRPV1 agonists.
  103. Muhammad, Naweed; Jamieson, Gene Curtis; Bley, Keith R.; Chanda, Sanjay, Methods and compositions for administration of TRPV1 agonists.
  104. Leech, Ronald L.; Hall Yung, Rachelle L.; Brzeczko, Albert W., Methods and compositions for deterring abuse.
  105. Leech, Ronald L.; Hall Yung, Rachelle L.; Brzeczko, Albert W., Methods and compositions for deterring abuse.
  106. Bonadio Jeffrey ; Goldstein Steven A., Methods and compositions for multiple gene transfer into bone cells.
  107. Patton, John S.; Foster, Linda S.; Platz, Robert M., Methods and compositions for pulmonary delivery of insulin.
  108. Brzeczko, Albert W.; Hollenbeck, R. Gary, Methods and compositions for self-regulated release of active pharmaceutical ingredient.
  109. Brzeczko, Albert W.; Hollenbeck, R. Gary, Methods and compositions for self-regulated release of active pharmaceutical ingredient.
  110. Vargas Rincon, Ricardo Alberto; Reiz, Joseph, Methods and compositions particularly for treatment of attention deficit disorder.
  111. Vargas Rincon, Ricardo Alberto; Reiz, Joseph, Methods and compositions particularly for treatment of attention deficit disorder.
  112. Bova David J., Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night.
  113. Cefali, Eugenio A.; Bova, David J., Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia.
  114. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of manufacturing oral dosage forms.
  115. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of manufacturing oral formulations.
  116. Eliaz, Rom Ezer; Zhang, Yuanpeng; Rohloff, Catherine Manya; Weeks, Eric William; Junnarkar, Gunjan, Methods of manufacturing viscous liquid pharmaceutical formulations.
  117. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of providing analgesia.
  118. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of providing analgesia.
  119. Bonadio, Jeffrey; Yin, Wushan, Methods of using latent TGF-β binding proteins.
  120. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  121. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  122. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  123. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  124. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  125. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  126. Tu, Yu-Hsing; Perumal, Ashok; Kathala, Kalyan, Methylphenidate extended release chewable tablet.
  127. Legrand, Valérie; Castan, Catherine; Meyrueix, Rémi; Soula, Gérard, Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles.
  128. Hermelin, Marc S.; Paradissis, George; Garegnani, James A., Mineral supplement.
  129. Hayes, David; LoPore, Angelo; Lukas, Stefan; Quinn, Eugene, Modified release coated drug preparation.
  130. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug - ion exchange resin complexes.
  131. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  132. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  133. Devane, John G.; Stark, Paul; Fanning, Niall M. M., Multiparticulate modified release composition.
  134. Devane, John G.; Stark, Paul; Fanning, Niall M. M.; Rekhi, Gurvinder Singh, Multiparticulate modified release composition.
  135. Devane, John G; Stark, Paul; Fanning, Niall M. N.; Rekhi, Gurvinder Singh; Jenkins, Scott A.; Liversidge, Gary, Nanoparticulate and controlled release compositions comprising cefditoren.
  136. Haslwanter, Joseph A.; Rencher, William F., Nasal spray compositions.
  137. Bova David J., Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  138. Bova, David J, Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  139. Sriwongjanya,Mongkol; Weng,Timothy; Barman,David; Kositprapa,Unchalee, Once a day antihistamine and decongestant formulation.
  140. Chen Chih-Ming ; Chou Joseph C.H., Once daily calcium channel blocker tablet having a delayed release core.
  141. Chen Chih-Ming ; Chou Joseph C. H., Once daily pharmaceutical tablet having a unitary core.
  142. Chih-Ming Chen ; Joseph C. H. Chou, Once daily pharmaceutical tablet having a unitary core.
  143. Dixit, Manesh; Chen, Chih-Ming; Cheng, Xiu Xiu; Xie, Jianbo, Oral controlled release dosage form.
  144. Dixit, Manesh; Chen, Chih-Ming; Cheng, Xiu Xiu; Xie, Jianbo, Oral controlled release dosage form.
  145. Dixit, Manesh; Chen, Chih-Ming; Cheng, Xiu-Xiu; Xie, Jianbo, Oral controlled release dosage form.
  146. Mehta, Ketan; Tu, Yu-Hsing; Perumal, Ashok, Orally effective methylphenidate extended release powder and aqueous suspension product.
  147. Mehta, Ketan; Tu, Yu-Hsing; Perumal, Ashok, Orally effective methylphenidate extended release powder and aqueous suspension product.
  148. Mehta, Ketan; Tu, Yu-Hsing; Perumal, Ashok, Orally effective methylphenidate extended release powder and aqueous suspension product.
  149. Mehta, Ketan; Tu, Yu-Hsing; Perumal, Ashok, Orally effective methylphenidate extended release powder and aqueous suspension product.
  150. Alessi, Thomas R.; Mercer, Ryan D.; Rohloff, Catherine M.; Yang, Bing, Osmotic delivery device comprising an insulinotropic peptide and uses thereof.
  151. Haslwanter Joseph A. ; Rencher William F., Oxymetazoline HCI and/or chlorpheniramine maleate nasal spray compositions.
  152. Hanna,Mazen H.; York,Peter, Particle formation methods and their products.
  153. York, Peter; Shekunov, Boris Yu; Rehman, Mahboob Ur; Feeley, Jane Catherine, Particulate materials.
  154. York, Peter; Shekunov, Boris Yu; Rehman, Mahboob Ur; Feeley, Jane Catherine, Particulate materials.
  155. York, Peter; Shekunov, Boris Yu; Rehman, Mahboob Ur; Feeley, Jane Catherine, Particulate materials.
  156. Flores, Luis Estrada; González, Alfonso Dueñas; García, Arturo Borbolla; Martinez, Raul Serna; Hernández, Alfredo Rivera; Betancourt, Alejandro Mohar, Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment.
  157. Curatolo, William J.; Shanker, Ravi M.; Babcock, Walter C.; Friesen, Dwayne T.; Nightingale, James A. S.; Lorenz, Douglas A., Pharmaceutical compositions providing enhanced drug concentrations.
  158. Curatolo, William J.; Shanker, Ravi M.; Babcock, Walter C.; Friesen, Dwayne T.; Nightingale, James A. S.; Lorenz, Douglas A., Pharmaceutical compositions providing enhanced drug concentrations.
  159. Curatolo, William J.; Shanker, Ravi M.; Babcock, Walter C.; Friesen, Dwayne T.; Nightingale, James A. S.; Lorenz, Douglas A., Pharmaceutical compositions providing enhanced drug concentrations.
  160. Curatolo, William J.; Shanker, Ravi M.; Babcock, Walter C.; Friesen, Dwayne T.; Nightingale, James A. S.; Lorenz, Douglas A., Pharmaceutical compositions providing enhanced drug concentrations.
  161. Curatolo, William J.; Shanker, Ravi M.; Babcock, Walter C.; Friesen, Dwayne T.; Nightingale, James A. S.; Lorenz, Douglas A., Pharmaceutical compositions providing enhanced drug concentrations.
  162. Kelm Gary Robert ; Kondo Koji,JPX ; Nakajima Akio,JPX, Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery.
  163. Bolt Ian James,GBX ; Merrifield David Roy,GBX ; Carter Paul Laurence,GBX, Pharmaceutical formulation with effervescent couple.
  164. Gordon, Douglas J., Phenylbutazone carrier formulation showing increased bioactivity in animals.
  165. Addicks William J ; Duda Joseph P ; Snider Daniel A. ; Benson Kerry R, Phenytoin sodium pharmaceutical compositions.
  166. Addicks, William J.; Duda, Joseph P.; Snider, Daniel A.; Benson, Kerry R., Phenytoin sodium pharmaceutical compositions.
  167. Weers, Jeffry G.; Tarara, Thomas E.; Dellamary, Luis A.; Riess, Jean G.; Schutt, Ernest G., Phospholipid-based powders for drug delivery.
  168. Weers, Jeffry G; Tarara, Thomas E; Dellamary, Luis A; Riess, Jean G; Schutt, Ernest G, Phospholipid-based powders for drug delivery.
  169. Sabel Bernhard A. (Egmating DEX) Freese Andrew (Jamaica Plain MA) Saltzman William M. (Baltimore MD) During Matthew J. (Westport CT), Polymeric device for controlled drug delivery to the CNS.
  170. Tuominen, Jukka; Zurutuza, Amaia; Livingstone, Mark; Halliday, Janet A., Polyurethane elastomers.
  171. Tuominen, Jukka; Zurutuza, Amaia; Livingstone, Mark; Halliday, Janet Anne, Polyurethane elastomers.
  172. Snyder, Herman E.; Nasiatka, James; Varga, Christopher M., Prefilming atomizer.
  173. Snyder, Herman E; Nasiatka, James; Varga, Christopher M, Prefilming atomizer.
  174. Bernstein Howard (Cambridge MA) Morrel Eric (Needham MA) Mathiowitz Edith (Brookline MA) Schwaller Kirsten (Duxbury MA) Beck Thomas R. (Concord MA), Protein microspheres and methods of using them.
  175. Patton,John S., Pulmonary delivery of active fragments of parathyroid hormone.
  176. Tarara, Thomas E.; Weers, Jeffry G.; Venthoye, Geraldine, Pulmonary delivery of aminoglycoside.
  177. Tarara, Thomas E; Weers, Jeffry G; Venthoye, Maria Geraldine, Pulmonary delivery of aminoglycoside.
  178. Tarara, Thomas E.; Weers, Jeffrey G.; Kabalnov, Alexey; Schutt, Ernest G.; Dellamary, Luis A., Pulmonary delivery particles comprising an active agent.
  179. Alessi, Thomas R.; Luskey, Kenneth, Rapid establishment and/or termination of substantial steady-state drug delivery.
  180. Bonadio Jeffrey ; Yin Wushan, Recombinant production of latent TGF-beta binding protein-3 (LTBP-3).
  181. Weers, Jeffry G.; Schutt, Ernest G.; Dellamary, Luis A.; Tarara, Thomas E.; Kabalnov, Alexey, Respiratory dispersion for metered dose inhalers comprising perforated microstructures.
  182. Johal, Sarjit; Pollmeier, Albert J., Salt composition.
  183. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  184. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  185. Roser, Bruce J.; Kampinga, Jaap; Colaco, Camilo; Blair, Julian, Solid dose delivery vehicle and methods of making same.
  186. Jain Rajeev A. ; Wei Linden ; Swanson Jon, Solid dose form of nanoparticulate naproxen.
  187. Rohloff, Catherine M.; Chen, Guohua; Luk, Andrew S.; Ayer, Rupal A.; Houston, Paul R.; Desjardin, Michael A.; Zamora, Pauline; Lam, Stan, Solvent/polymer solutions as suspension vehicles.
  188. Snyder, Herman E.; Vosberg, Michael J.; Varga, Christopher M., Spray drying methods and related compositions.
  189. Snyder, Herman E; Vosberg, Michael J; Varga, Christopher M, Spray drying methods and related compositions.
  190. Bennett, David B.; Brewer, Thomas K.; Platz, Robert M.; Snyder, Herman, Spray drying process control of drying kinetics.
  191. Bennett, David B; Brewer, Thomas K; Platz, Robert M; Snyder, Herman, Spray drying process control of drying kinetics.
  192. Robertson, Steven, Stabilised prostaglandin composition.
  193. Robertson, Steven, Stabilised prostaglandin composition.
  194. Robertson, Steven, Stabilised prostaglandin composition.
  195. Weers, Jeffry G.; Schutt, Ernest G.; Dellamary, Luis; Tarara, Thomas E.; Kabalnov, Alexey, Stabilized preparations for use in metered dose inhalers.
  196. Dellamary, Luis A.; Reiss, Jean; Schutt, Ernest G.; Weers, Jeffry G.; Tarara, Thomas E., Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery.
  197. Dellamary, Luis A.; Riess, Jean; Schutt, Ernest G.; Weers, Jeffry G.; Tarara, Thomas E., Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use.
  198. Dellamary, Luis A; Riess, Jean; Schutt, Ernest G; Weers, Jeffry G; Tarara, Thomas E, Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use.
  199. Berry, Stephen A.; Fereira, Pamela J.; Dehnad, Houdin; Muchnik, Anna, Stable non- aqueous single phase viscous vehicles and formulations utilizing such vehicles.
  200. Berry,Stephen A.; Fereira,Pamela J.; Dehnad,Houdin; Muchnik,Anna, Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle.
  201. Berry, Stephen A.; Fereira, Pamela J.; Dehnad, Houdin; Muchnik, Anna, Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles.
  202. Berry, Stephen A.; Fereira, Pamela J.; Dehnad, Houdin; Muchnik, Anna, Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles.
  203. Berry, Stephen A.; Fereira, Pamela J.; Dehnad, Houdin; Muchnik, Anna, Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles.
  204. Berry, Stephen A.; Fereira, Pamela J.; Dehnad, Houdin; Muchnik, Anna, Stable non-aqueous single phase viscous vehicles and formulations utlizing such vehicles.
  205. Chen Jianbing ; Ashton Paul, Sustained release drug delivery devices.
  206. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  207. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  208. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  209. Guo, Hong; Ashton, Paul, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  210. Hong Guo ; Paul Ashton, Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof.
  211. Baichwal, Anand R.; Goliber, Philip A.; Carpanzano, Anthony E.; Sciascia, Thomas; Diehl, Donald; Vogler, Brian; Verbel, David; Au, Stanley, Sustained release formulation of nalbuphine.
  212. Baichwal, Anand R.; Goliber, Philip A.; Carpanzano, Anthony E.; Sciascia, Thomas; Diehl, II, Donald; Vogler, Brian, Sustained release formulation of nalbuphine.
  213. Baichwal, Anand R.; Goliber, Philip A.; Carpanzano, Anthony E.; Sciascia, Thomas; Diehl, II, Donald; Vogler, Brian; Verbel, David; Au, Stanley, Sustained release formulation of nalbuphine.
  214. Baichwal, Anand R.; Goliber, Philip A.; Carpanzano, Anthony E.; Sciascia, Thomas; Diehl, II, Donald; Vogler, Brian; Verbel, David; Au, Stanley, Sustained release formulation of nalbuphine.
  215. Baichwal, Anand R.; Goliber, Philip A.; Carpanzano, Anthony E.; Sciascia, Thomas; Diehl, II, Donald; Vogler, Brian, Sustained release formulations of nalbuphine.
  216. Gordon, Marc S.; Clark, Andrew; Brewer, Thomas K., Systems and processes for spray drying hydrophobic and hydrophilic components.
  217. Venkataraman, Balaji, Tannate compositions and methods of treatment.
  218. McTeigue,Daniel; Parikh,Narenda; Wynn,David W.; Pillai,Ravivaj S., Teste masked pharmaceutical particles.
  219. Alessi, Thomas R.; Baron, Michelle, Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c.
  220. Peroutka, Stephen; Swarbrick, James, Threo-DOPS controlled release formulation.
  221. Peroutka, Stephen; Swarbrick, James, Threo-DOPS controlled release formulation.
  222. Peroutka, Stephen; Swarbrick, James, Threo-DOPS controlled release formulation.
  223. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  224. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  225. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  226. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  227. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  228. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  229. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  230. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  231. Lautenbach, Scott C.; De La Serna, Pedro E.; Zamora, Pauline C.; Desjardin, Michael A., Two-piece, internal-channel osmotic delivery system flow modulator.
  232. Wolfgang Ebert DE; Ralf Hufen DE; Wilfried Haese DE, Use of saccharin for stabilizing thermoplastic, aromatic polycarbonates.
  233. Aubert Daniel (Plaisance du Touch FRX) Blanc Francis (Lattes FRX) Desmolin Henri (Merignac FRX) Morre Michel (Toulouse FRX) Sindely Lucette (Andre de Cubzac FRX), Valproic acid preparations.
  234. Bartels, Jennifer, Veterinary topical agent.
  235. Halliday, Janet A.; Tuominen, Jukka; Livingstone, Mark; Koppenhagen, Frank; Currie, Lilias; Stewart, Sarah, Water-swellable polymers.
  236. Halliday, Janet A.; Tuominen, Jukka; Livingstone, Mark; Koppenhagen, Frank; Currie, Lilias; Stewart, Sarah, Water-swellable polymers.
  237. Halliday, Janet Anne; Tuominen, Jukka; Livingstone, Mark Alexander; Koppenhagen, Frank; Currie, Lilias Morton; Stewart, Sarah, Water-swellable polymers.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로